Tripletail Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026Tripletail Wealth Management, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $2.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$2.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 710 | $664K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 11,142 | $632K |
| ABBVAbbVie Inc. | 2,579 | $539K |
| AMGNAMGEN INC | 812 | $283K |
| MRKMerck & Co., Inc. | 2,053 | $248K |
| GEHCGE HealthCare Technologies Inc. | 2,101 | $148K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 290 | $127K |
| NVSNovartis AG | 590 | $91K |
| LNTHLantheus Holdings, Inc. | 960 | $73K |
| JNJJOHNSON & JOHNSON | 260 | $63K |
| BMYBRISTOL MYERS SQUIBB CO | 376 | $22K |
| NVONovo Nordisk A/S | 158 | $6K |
| ZBHZimmer Biomet Holdings Inc. | 55 | $5K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 10 | $3K |
| ABTABBOTT LABORATORIES | 26 | $3K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9 | $2K |
| CGCCanopy Growth Corp | 900 | $900 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.